Anxiety Peptide Stack: Selank + Oxytocin + DSIP
A three-peptide intranasal stack popular in biohacker communities for anxiolytic, social-calm, and deep-sleep effects without the SSRI/benzodiazepine side-effect profile. Selank for daytime calm, oxytocin for social situations, DSIP for sleep onset. Here is the mechanism, the dosing, and the honest evidence picture.
Range
Research Dose
Dose
How It Works
TP-21 / Selank modulates GABA-A and serotonergic systems without sedation or dependency potential. Russian regulatory peptide. Fast onset (5-15 min intranasal), 6-8 hour duration. Daytime anxiolytic without cognitive blunt.
Activates oxytocin receptors in amygdala, NAcc, hypothalamus. Reduces threat reactivity in social settings. Effects peak ~30-60 min after intranasal. Replication issues mean effect sizes are smaller and less reliable than the early literature suggested.
Delta Sleep-Inducing Peptide. Modulates HPA axis and supports delta-wave sleep onset. Evening dosing aligns with natural circadian sleep onset. Limited human trial data but consistent reports of reduced sleep latency.
Daily for 10-20 days followed by 1-2 week break is common. Receptor desensitization is a theoretical concern with chronic use. Some users run Selank+DSIP only, adding oxytocin pre-social events on demand.
What the Data Shows
Key Takeaways
- Three intranasal peptides with distinct mechanisms: Selank (GABA+5HT), oxytocin (OXTR), DSIP (sleep)
- Each component has independent rationale; combined-stack RCT data does not exist
- Selank typical: 100-500 mcg per dose, 1-3× daily for 10-20 days then break
- Oxytocin typical: 24 IU per dose, often used pre-social on-demand
- DSIP typical: 100-200 mcg in the evening (some protocols include morning dose)
- Side-effect burden generally lower than SSRIs or benzodiazepines
- No documented dependency, but cycling is recommended to avoid receptor desensitization
- Whether the combined stack outperforms any single component
- Long-term safety of chronic intranasal self-administration
- How effects compare to validated SSRIs / SNRIs head-to-head
- Whether Selank works for clinical generalized anxiety disorder vs subclinical anxiety
- Optimal timing within a daily protocol (combine, separate, when)
Frequently Asked Questions
What is the Selank + Oxytocin + DSIP stack?
A three-peptide intranasal stack used off-label for anxiety, social comfort, and sleep without the side-effect profile of SSRIs or benzodiazepines. Selank handles daytime anxiolytic baseline; oxytocin is used acutely before social events; DSIP supports evening sleep onset. Most users run Selank + DSIP daily and add oxytocin on-demand. Each peptide is delivered intranasally for direct nose-to-brain absorption.
Is this stack safer than SSRIs?
Lower side-effect burden does not equal "safer." The peptides are not FDA-approved for anxiety, lack large-scale safety data, and have no established withdrawal profile. SSRIs are FDA-approved with decades of safety follow-up; their side-effects are known and managed clinically. The peptide stack avoids common SSRI side-effects (sexual dysfunction, sleep disruption, weight gain) but trades them for unknowns. For clinically diagnosed anxiety disorders, evidence-based SSRI/CBT is first-line.
How do I dose each peptide?
Selank: 100-500 mcg intranasal, 1-3× daily, cycled 10-20 days on / 1-2 weeks off. Oxytocin: 24 IU intranasal as needed before social events (peak effect 30-60 min). DSIP: 100-200 mcg intranasal in the evening, ~30 minutes before bed. These are research-protocol doses, not clinically validated.
Does this stack work for panic attacks?
Selank has fast onset (5-15 min) and is reported by users to attenuate acute anxiety, but data on panic-attack-specific use is anecdotal. For diagnosed panic disorder, evidence-based treatments (SSRI, CBT, sometimes benzodiazepine) remain first-line. Discuss any addition of off-label peptides with a prescriber, especially if you take other psychiatric medications.
Where do I get these peptides?
Selank, oxytocin, and DSIP are restricted from compounding in the US as of April 2026. The July 2026 PCAC hearing reviews DSIP for the 503A bulks list. Research-grade peptide vendors sell all three but for "laboratory use only." Quality variance is significant; third-party COAs are the exception not the rule.
🔬 Research-Grade Source
Swiss Chems publishes third-party HPLC COAs for every batch. HighPeptides' primary vendor reference for peptides.
Browse Swiss Chems →Affiliate link — supports HighPeptides at no extra cost
🛒 Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links — support HighPeptides at no extra cost.
Educational purposes only. Not medical advice.
For diagnosed anxiety disorders, evidence-based treatments (SSRI, CBT) are first-line. Discuss off-label peptide use with a qualified prescriber.